Brief: CytoTools Examines Effectiveness Of Patented Active Substance DPOCL In Covid-19 Infections

bioXXmed AG

17/09/2020 09:46

Sept 17 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * CYTOTOOLS EXAMINES EFFECTIVENESS OF ITS PATENTED ACTIVE
SUBSTANCE DPOCL IN COVID-19 INFECTIONS
    * ANTI-VIRAL EFFECT OF DPOCL DEMONSTRATED IN FIRST CELLULAR
TEST
SYSTEMS
    * CYTOTOOLS EXPECTS FIRST MEANINGFUL RESULTS OF TESTS WITHIN
NEXT
FOUR TO SIX WEEKS
    * COMPANY IS AIMING FOR A SHORT-TERM OUT-LICENSING OF
PROJECT IN
EVENT OF POSITIVE RESULTS

Source text for Eikon:  ID:nEQk5Bdda 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))